ERCC1 and RRM1 as a predictive parameter for non-small cell lung, ovarian or pancreas cancer treated with cisplatin and/or gemcitabine


Ulker M., Duman B. B. , ŞAHİN B. , GÜMÜRDÜLÜ D.

WSPOLCZESNA ONKOLOGIA-CONTEMPORARY ONCOLOGY, cilt.19, ss.207-213, 2015 (ESCI İndekslerine Giren Dergi) identifier identifier identifier

  • Cilt numarası: 19 Konu: 3
  • Basım Tarihi: 2015
  • Doi Numarası: 10.5114/wo.2015.52656
  • Dergi Adı: WSPOLCZESNA ONKOLOGIA-CONTEMPORARY ONCOLOGY
  • Sayfa Sayısı: ss.207-213

Özet

Background: We aimed to investigate the impact of RRM1 and ERCC1 expression on response to cisplatin and/or gemcitabine chemotherapy in patients with lung, ovarian or pancreatic cancer.